Extent of Resection Versus Molecular Classification: What Matters When?
Sign Up to like & getrecommendations! Published in 2019 at "Neurosurgery clinics of North America"
DOI: 10.1016/j.nec.2018.08.006
Abstract: For malignant gliomas, the survival benefit of new combination therapies after surgical resection is measured in weeks to months. In contrast, optimizing treatment for low-grade gliomas can potentially provide additional years of life. The relatively… read more here.
Keywords: molecular classification; extent resection; versus molecular; resection versus ... See more keywords